Methods to determine lung distribution of inhaled drugs - Could gamma scintigraphy be the gold standard?

British Journal of Clinical Pharmacology

Volumn 49, Issue 6, 2000, Pages 525-528

  Chrystyn, Henry ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CROMOGLYCATE DISODIUM; FLUTICASONE; METHACHOLINE; SALBUTAMOL; VIRUS PROTEIN;

BIOEQUIVALENCE; DOSE RESPONSE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG URINE LEVEL; EDITORIAL; GAMMA SCINTIGRAPHY; HUMAN; ISOTOPE LABELING; LUNG SCINTISCANNING; METERED DOSE INHALER; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; GAMMA RAYS; HUMANS; LUNG; PHARMACEUTICAL PREPARATIONS; RADIONUCLIDE IMAGING;

EID: 0034127151     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00215.x     Document Type: Editorial

References (24)

1. 1 Newman SP. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs? Br J Clin Pharmacol 2000; 49: 529-537.
2. 2 Newman SP, Morén F, Trufast E, Talaee N, Clarke SW. Terbutaline sulphate. Turbohaler effect of inhaled flow rate on drug deposition and efficacy. Int J Pharm 1991; 74: 209-213.
3. 3 Chrystyn H. Is total particle dose more important than particle disribution? Respir Med 1997; 91(Suppl A): 17-19.
4. 4 Dahl R, Lundback B, Malo JL, Mazza JA, Saarelainen P, Barnacle H. A dose-ranging study of fluticasone propionate in adult pataients with moderate asthma. International Study group. Chest 1993; 104: 1352-1358.
5. 5 Raphael GD, Lanier RQ, Baker J, Edwards L, Rickard K, Lincourt BS. A comparison of multiple doses of fluticasone propionate and beclomethasone diproprionate in subjects with persistent asthma. J Allergy Clin Immunol 1999; 103: 796-803.
6. 6 Barnes PJ, Pride NB. Dose response curves to inhaled β-adrenoceptor agonists in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15: 677-682.
7. 7 Newman SP, Talaee N, Clarke SW. Salbutamol aerosol delivery in man with the Rondo Spacer. Acta Therapeutica 1991; 17: 49-50.
8. 1 as HFA-BDP. Am J Resp Crit Care Med 1998; 157: A405.
9. 9 Leach CL, Davidson PJ, Boudreau RJ. Improved airway targetting with the CFC-free HFA-beclomethasone metered dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998; 12: 346-353.
10. 10 Hamid QA, Ying LL, Minshall E, Elliott M, Hogg JC. Immunocytochemical study of inflammation in airways of surgically resected lungs from asthmatic and non-asthmatic subjects. J Allergy Clin Immunol 1996; 97: 355.
11. 11 Adams WP, Pouchikian G, Taylor AS, et al. Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and developments of generic substitutes. J Aerosol Med 1994; 7: 119-134.
12. 20). Eur Respir J 1999; 14: 328.
13. 13 Newman SP, Pavia D, Garland N, Clarke SW. Effect of various inhalation modes on the depostion of radioactive pressurised aerosols. Eur J Respir Dis 1982; 119(Suppl): 57-65.
14. 14 Newnham DM, McDevitt DG, Lipworth BJ. Comparison of the extrapulmonary responses and pharmacokinetics of salbutamol given by standard metered dose inhaler and modified actuator devices. Br J Clin Pharmacol 1993; 36: 445-450.
15. 15 Derendorf H, Huchhaus G, Meibohm B, Mollman H, Barth J. Pharamacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998; 101: S440-S446.
16. 16 Borgström L, Newman S, Weisz A, Morén F. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods. J Pharm Sci 1992; 81: 753-755.
17. 17 Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34: 311-315.
18. 18 Aydin M, Meakin BJ, Staniforth JN, Woodhouse CE. Comparative deposition of 99m Tc labelled and unlabelled terbutaline in a 5-stage liquid impinger. Pharm Res 1997; 14: S134.
19. 19 Newman SP, Steed KP, Hooper G, Jones JI, Upchurch FC. Improved targeting of beclomethasone dipropionate to the lungs of asthmatics with Spacehaler. Respir Med 1999; 93: 424-431.
20. 20 El Araud KA, Clark BJ, Kaahwa C, Anum P, Chrystyn H. The effect of dose on the characterization of aerodynamic particle-size of distributions of beclomethasone dipropionate metered dose inhalers. J Pharm Pharmacol 1998; 50: 1081-1085.
21. 21 Snell NJC, Ganderton D. British Association of Lung Research Consensus Statement. Respir Med 1999; 93: 123-133.
22. 22 Newman SP, Clark AR, Talaee N, Clarke SW. Lung deposition of 5 mg Intal from a pressurised metered dose inhaler assessed by radiotracer technique. Int J Pharm 1999; 74: 203-208.
23. 23 Aswania OA, Corlett SA, Chrystyn H. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion. Br J Clin Pharmacol 1999; 47: 613-618.
24. 24 Seale JP, Harrison LJ. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics. Respir Med 1998; 92(Suppl A): 9-15.